Who owns Fennec Pharmaceuticals Inc?
- Ticker: FENC
- CUSIP Number: 31447p100
Tip: Access positions for across all investors
Analyze quarterly positions in Fennec Pharmaceuticals with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Fennec Pharmaceuticals stock
Who bought or sold Fennec Pharmaceuticals Inc this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Southpoint Capital Advisors | 4.1M | $20M | 0% | Sep 2024 |
|
| Sonic GP | 2.4M | $12M | 0% | Sep 2024 |
|
| Solas Capital Management | 1.9M | $9.6M | 44% | Sep 2024 |
|
| DG Capital Management | 1.5M | $7.6M | -7% | Sep 2024 |
|
| BlackRock | 1.2M | $6.1M | 100% | Sep 2024 |
|
| Vanguard Group | 1.0M | $5.2M | 2% | Sep 2024 |
|
| Harbert Fund Advisors | 467k | $2.3M | 0% | Sep 2024 |
|
| State Street Corporation | 328k | $1.6M | 2% | Sep 2024 |
|
| Geode Capital Management | 299k | $1.5M | -1% | Sep 2024 |
|
| Jeffrey L. Gendell | 232k | $1.2M | -18% | Sep 2024 |
|
| Lion Point Capital | 215k | $1.1M | 26% | Sep 2024 |
|
| Northern Trust | 140k | $699k | 100% | Sep 2024 |
|
| Winton Capital | 72k | $358k | 7% | Sep 2024 |
|
| Russell Investments | 60k | $299k | 12% | Sep 2024 |
|
| Charles Schwab Investment Management | 56k | $277k | 0% | Sep 2024 |
|
| Goldman Sachs Group | 54k | $269k | 167% | Sep 2024 |
|
| Advantage Alpha Capital Partners | 53k | $264k | 100% | Sep 2024 |
|
| Bank of New York Mellon | 52k | $259k | -25% | Sep 2024 |
|
| Hartford Financial Management | 50k | $315k | 2% | Dec 2024 |
|
| Qube Research & Technologies | 49k | $244k | 4% | Sep 2024 |
|
| Bnp Paribas Arbitrage, Snc | 40k | $200k | -15% | Sep 2024 |
|
| Barclays | 31k | $157k | 274% | Sep 2024 |
|
| Rhumbline Advisers | 30k | $152k | 4% | Sep 2024 |
|
| Sherbrooke Park Advisers | 30k | $148k | 4% | Sep 2024 |
|
| Bank of America Corporation | 27k | $136k | 3% | Sep 2024 |
|
| Wexford Capital | 26k | $132k | 100% | Sep 2024 |
|
| Nuveen Asset Management | 26k | $130k | 0% | Sep 2024 |
|
| State of Wisconsin Investment Board | 24k | $122k | 87% | Sep 2024 |
|
| Jane Street | 19k | $97k | -2% | Sep 2024 |
|
| Citigroup | 17k | $86k | 158% | Sep 2024 |
|
| Franklin Resources | 15k | $67k | 19% | Sep 2024 |
|
| Millennium Management | 14k | $71k | -79% | Sep 2024 |
|
| Mirae Asset Global Etfs Holdings | 13k | $64k | 31% | Sep 2024 |
|
| Deutsche Bank Aktiengesellschaft | 12k | $62k | 0% | Sep 2024 |
|
| UBS Group | 11k | $56k | 54% | Sep 2024 |
|
| Verition Fund Management | 11k | $53k | -69% | Sep 2024 |
|
| Jpmorgan Chase & Co | 11k | $53k | 2% | Sep 2024 |
|
| American Alpha Advisors | 10k | $50k | 100% | Sep 2024 |
|
| Wells Fargo & Company | 10k | $50k | 3% | Sep 2024 |
|
| New York State Common Retirement Fund | 9.8k | $49k | 0% | Sep 2024 |
|
| Jones Financial Companies, L.L | 5.8k | $30k | 100% | Sep 2024 |
|
| Royal Bank of Canada | 3.0k | $18k | 37% | Sep 2024 |
|
| Legal & General Group | 2.5k | $12k | 0% | Sep 2024 |
|
| Tower Research Capital | 2.4k | $12k | -46% | Sep 2024 |
|
| California State Teachers Retirement System | 1.7k | $8.5k | 0% | Sep 2024 |
|
| State of Wyoming | 1.6k | $8.1k | -7% | Sep 2024 |
|
| Atlantic Trust | 1.6k | $7.8k | 0% | Sep 2024 |
|
| Summit Investment Advisors | 1.5k | $7.5k | 0% | Sep 2024 |
|
| Lazard Asset Management | 1.4k | $6.0k | -22% | Sep 2024 |
|
| FMR | 1.2k | $5.9k | 4% | Sep 2024 |
|
| Massmutual Trust | 982.00 | $6.2k | 1593% | Dec 2024 |
|
| Amalgamated Bank | 612.00 | $3.0k | 0% | Sep 2024 |
|
| NISA Investment Advisors | 377.00 | $2.4k | 40% | Dec 2024 |
|
| Private Wealth Management Group | 247.00 | $1.6k | 100% | Dec 2024 |
|
| Advisor Group Holdings | 245.00 | $1.2k | 100% | Sep 2024 |
|
| CWM | 129.00 | $999.995100 | 249% | Sep 2024 |
|
| Cornerstone Planning Group | 88.00 | $576.004000 | 0% | Dec 2024 |
|
| Sterling Capital Management | 62.00 | $310.000000 | 100% | Sep 2024 |
|
| Simplex Trading | 21.00 | $0 | 100% | Sep 2024 |
|
| Capital Performance Advisors | 5.00 | $25.000000 | 100% | Sep 2024 |
|
| Goss Wealth Management | 1.00 | $5.000000 | -100% | Sep 2024 |
|
Who sold out of Fennec Pharmaceuticals?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| CIBC World Markets | Sep 2024 | 27k | $133k |
| Hillsdale Investment Management | Jun 2024 | 25k | $150k |
| Squarepoint Ops | Jun 2024 | 18k | $108k |
| Pinnacle Wealth Planning Services | Jun 2024 | 12k | $75k |
| Manufacturers Life Insurance Company | Jun 2024 | 11k | $69k |
| Acadian Asset Management | Jun 2024 | 8.1k | $49k |
| MetLife Investment Advisors | Jun 2024 | 4.5k | $28k |
| Pnc Financial Services | Jun 2024 | 112.00 | $683.995200 |
| Covestor | Jun 2024 | 77.00 | $0 |